London, November 16 Britain’s medicines regulator has authorised the world’s first gene therapy treatment for sickle cell disease, in a move that could offer relief to thousands of people with the crippling disease in the UK. In a statement on Thursday, the Medicines and Healthcare Regulatory Agency (MHRA) said it approved Casgevy, the first medicine…